Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

Alette M. Wessels, Robert Bies, Bruce G. Pollock, Lon S. Schneider, Jeffrey A. Lieberman, Scott Stroup, Claire H. Li, Kim Coley, Margaret M. Kirshner, Stephen R. Marder

Research output: Contribution to journalArticle

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)1587-1591
Number of pages5
JournalJournal of Clinical Pharmacology
Volume51
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Piperazines
Thiazoles
Double-Blind Method
Antipsychotic Agents
Young Adult
Schizophrenia
Pharmacokinetics
Population
ziprasidone

Keywords

  • population pharmacokinetics
  • schizophrenia
  • ziprasidone

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Wessels, A. M., Bies, R., Pollock, B. G., Schneider, L. S., Lieberman, J. A., Stroup, S., ... Marder, S. R. (2011). Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. Journal of Clinical Pharmacology, 51(11), 1587-1591. https://doi.org/10.1177/0091270010387604

Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. / Wessels, Alette M.; Bies, Robert; Pollock, Bruce G.; Schneider, Lon S.; Lieberman, Jeffrey A.; Stroup, Scott; Li, Claire H.; Coley, Kim; Kirshner, Margaret M.; Marder, Stephen R.

In: Journal of Clinical Pharmacology, Vol. 51, No. 11, 11.2011, p. 1587-1591.

Research output: Contribution to journalArticle

Wessels, AM, Bies, R, Pollock, BG, Schneider, LS, Lieberman, JA, Stroup, S, Li, CH, Coley, K, Kirshner, MM & Marder, SR 2011, 'Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study', Journal of Clinical Pharmacology, vol. 51, no. 11, pp. 1587-1591. https://doi.org/10.1177/0091270010387604
Wessels, Alette M. ; Bies, Robert ; Pollock, Bruce G. ; Schneider, Lon S. ; Lieberman, Jeffrey A. ; Stroup, Scott ; Li, Claire H. ; Coley, Kim ; Kirshner, Margaret M. ; Marder, Stephen R. / Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. In: Journal of Clinical Pharmacology. 2011 ; Vol. 51, No. 11. pp. 1587-1591.
@article{88193e321e5f4ead8fa1e419ec1ff9fc,
title = "Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study",
keywords = "population pharmacokinetics, schizophrenia, ziprasidone",
author = "Wessels, {Alette M.} and Robert Bies and Pollock, {Bruce G.} and Schneider, {Lon S.} and Lieberman, {Jeffrey A.} and Scott Stroup and Li, {Claire H.} and Kim Coley and Kirshner, {Margaret M.} and Marder, {Stephen R.}",
year = "2011",
month = "11",
doi = "10.1177/0091270010387604",
language = "English",
volume = "51",
pages = "1587--1591",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

AU - Wessels, Alette M.

AU - Bies, Robert

AU - Pollock, Bruce G.

AU - Schneider, Lon S.

AU - Lieberman, Jeffrey A.

AU - Stroup, Scott

AU - Li, Claire H.

AU - Coley, Kim

AU - Kirshner, Margaret M.

AU - Marder, Stephen R.

PY - 2011/11

Y1 - 2011/11

KW - population pharmacokinetics

KW - schizophrenia

KW - ziprasidone

UR - http://www.scopus.com/inward/record.url?scp=79957521017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957521017&partnerID=8YFLogxK

U2 - 10.1177/0091270010387604

DO - 10.1177/0091270010387604

M3 - Article

C2 - 21209243

AN - SCOPUS:79957521017

VL - 51

SP - 1587

EP - 1591

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 11

ER -